https://www.pharmaradar360.com/article/scientists-found-a-cannabis-compound-that-relieves-pain-without-the-high-40735f2b86392634Pharma Surgeen2026-06-20T15:33:51.000ZScientists found a cannabis compound that relieves pain without the highhttps://www.pharmaradar360.com/article/this-dna-repair-gene-went-rogue-and-exposed-a-cancer-weakness-c06077b5d7503918Pharma Surgeen2026-06-20T12:27:35.000ZThis DNA repair gene went rogue and exposed a cancer weaknesshttps://www.pharmaradar360.com/article/ozempic-changed-obesity-treatment-but-experts-say-the-real-revolution-is-next-9ec9bda307a8dbfcPharma Surgeen2026-06-20T11:28:46.000ZOzempic changed obesity treatment, but experts say the real revolution is nexthttps://www.pharmaradar360.com/article/therapy-for-stage-iv-non-small-cell-lung-cancer-with-driver-alterations-asco-liv-c8c509e4442e2a86Pharma Surgeen2026-06-20T07:00:00.000ZTherapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, 2026.3.1https://www.pharmaradar360.com/article/therapy-for-stage-iv-non-small-cell-lung-cancer-without-driver-alterations-asco-fa729545754d224ePharma Surgeen2026-06-20T07:00:00.000ZTherapy for Stage IV Non–Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, 2026.3.1https://www.pharmaradar360.com/article/lessons-from-gbm-agile-s-regorafenib-experience-in-newly-diagnosed-and-recurrent-a2691796a2c41276Pharma Surgeen2026-06-20T07:00:00.000ZLessons From GBM AGILE's Regorafenib Experience in Newly Diagnosed and Recurrent Glioblastomahttps://www.pharmaradar360.com/article/long-term-efficacy-and-safety-of-taletrectinib-in-patients-with-ros1-non-small-c-2d8d5b2983621c9fPharma Surgeen2026-06-20T07:00:00.000ZLong-Term Efficacy and Safety of Taletrectinib in Patients With ROS1+ Non–Small Cell Lung Cancer: Results From the Phase II TRUST-I Studyhttps://www.pharmaradar360.com/article/reply-to-treatment-switching-and-subsequent-therapy-confound-overall-survival-es-f7b548b4462b512dPharma Surgeen2026-06-20T07:00:00.000ZReply to: Treatment Switching and Subsequent Therapy Confound Overall Survival Estimates in PHAROShttps://www.pharmaradar360.com/article/reply-to-signal-worth-trusting-if-we-can-reproduce-it-clarifying-overall-respons-1d076353514f8771Pharma Surgeen2026-06-20T07:00:00.000ZReply to: Signal Worth Trusting—If We Can Reproduce It: Clarifying Overall Response Rate and Progression-Free Survival in BEACON Immunohttps://www.pharmaradar360.com/article/menopausal-hormone-therapy-after-breast-cancer-personalization-not-prohibition-6c7ef606352e6cd3Pharma Surgeen2026-06-20T07:00:00.000ZMenopausal Hormone Therapy After Breast Cancer: Personalization, Not Prohibitionhttps://www.pharmaradar360.com/article/cracks-in-the-estrogen-carcinogenesis-of-breast-cancer-fc65f1bac5694641Pharma Surgeen2026-06-20T07:00:00.000ZCracks in the Estrogen Carcinogenesis of Breast Cancerhttps://www.pharmaradar360.com/article/signal-worth-trusting-if-we-can-reproduce-it-clarifying-overall-response-rate-an-10c782472bb13067Pharma Surgeen2026-06-20T07:00:00.000ZSignal Worth Trusting—If We Can Reproduce It: Clarifying Overall Response Rate and Progression-Free Survival in BEACON Immunohttps://www.pharmaradar360.com/article/multicenter-randomized-phase-ii-trial-of-olaparib-plus-radium-223-versus-radium-68cb1b45f4ed21d7Pharma Surgeen2026-06-20T07:00:00.000ZMulticenter, Randomized, Phase II Trial of Olaparib Plus Radium-223 Versus Radium-223 in Men With Castration-Resistant Prostate Cancer With Bone Metastases (COMRADE)https://www.pharmaradar360.com/article/treatment-switching-and-subsequent-therapy-confound-overall-survival-estimates-i-0a1f9feab7c0d141Pharma Surgeen2026-06-20T07:00:00.000ZTreatment Switching and Subsequent Therapy Confound Overall Survival Estimates in PHAROShttps://www.pharmaradar360.com/article/expert-opinion-on-the-diagnosis-and-treatment-of-hematologic-malignancies-during-651d3c6f62e7de6cPharma Surgeen2026-06-20T07:00:00.000ZExpert Opinion on the Diagnosis and Treatment of Hematologic Malignancies During Pregnancyhttps://www.pharmaradar360.com/article/neoadjuvant-single-cycle-pembrolizumab-for-stage-i-iii-mmr-deficient-colon-cance-9b6bcc718272c052Pharma Surgeen2026-06-20T07:00:00.000ZNeoadjuvant Single-Cycle Pembrolizumab for Stage I-III MMR-Deficient Colon Cancer: The RESET-C Trialhttps://www.pharmaradar360.com/article/ficerafusp-alfa-bca101-with-pembrolizumab-for-recurrent-or-metastatic-head-and-n-f47be6df5da460a3Pharma Surgeen2026-06-20T07:00:00.000ZFicerafusp Alfa (BCA101) With Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Two-Year Results of an Expansion Cohort of a Phase I/Ib Trialhttps://www.pharmaradar360.com/article/evaluation-of-regorafenib-in-newly-diagnosed-and-recurrent-glioblastoma-gbm-agil-30741e411920454bPharma Surgeen2026-06-20T07:00:00.000ZEvaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trialhttps://www.pharmaradar360.com/article/malignant-adult-ovarian-germ-cell-tumors-an-international-multicenter-study-to-i-ff91fb7f41cde9a0Pharma Surgeen2026-06-20T07:00:00.000ZMalignant Adult Ovarian Germ Cell Tumors: An International Multicenter Study to Identify Relevant Prognostic Risk Factors for Stage IC and Beyondhttps://www.pharmaradar360.com/article/glucocorticoid-and-mitophagy-signaling-based-molecular-subtyping-reveals-hmga1-a-c72453d7c1024a5aPharma Surgeen2026-06-20T00:00:00.000ZGlucocorticoid and mitophagy signaling–based molecular subtyping reveals HMGA1 as a prognostic and immunotherapy biomarker in lung adenocarcinomahttps://www.pharmaradar360.com/article/sgi-7079-as-a-novel-type-i-flt3-inhibitor-overcomes-resistance-to-gilteritinib-a-b9628db115a3379fPharma Surgeen2026-06-20T00:00:00.000ZSGI-7079 as a novel type I FLT3 inhibitor overcomes resistance to gilteritinib and quizartinib mediated by ITD and TKD mutations in acute myeloid leukemiahttps://www.pharmaradar360.com/article/hmgb3-facilitates-malignant-phenotype-of-esophageal-carcinoma-via-histone-lactyl-c0c1aa6f269a7e73Pharma Surgeen2026-06-20T00:00:00.000ZHMGB3 facilitates malignant phenotype of esophageal carcinoma via histone lactylation- and Wnt/β-catenin-dependent transcription activation of c-mychttps://www.pharmaradar360.com/article/clinical-responses-to-trastuzumab-deruxtecan-in-molecularly-defined-ependymoma-c573925998b5e35cPharma Surgeen2026-06-20T00:00:00.000ZClinical responses to trastuzumab deruxtecan in molecularly defined ependymomahttps://www.pharmaradar360.com/article/natco-records-e2-82-b9816-9-crore-consolidated-revenue-and-e2-82-b9269-0-crore-o-f672c35024810b79Pharma Surgeen2026-06-20T00:00:00.000Znatco records %e2%82%b9816 9 crore consolidated revenue and %e2%82%b9269 0 crore of profit after tax for q4 fy26 and %e2%82%b94375 9 crore of revenue %e2%82%b91418 5 crore profit after tax for fy26https://www.pharmaradar360.com/article/natco-records-e2-82-b9705-4-crore-consolidated-revenue-and-e2-82-b9151-3-crore-o-4b5fb321f094b641Pharma Surgeen2026-06-20T00:00:00.000Znatco records %e2%82%b9705 4 crore consolidated revenue and %e2%82%b9151 3 crore of profit after tax for q3fy26https://www.pharmaradar360.com/article/natco-records-e2-82-b91463-crore-consolidated-revenue-and-e2-82-b9517-9-crore-of-6e9def221c080e51Pharma Surgeen2026-06-20T00:00:00.000Znatco records %e2%82%b91463 crore consolidated revenue and %e2%82%b9517 9 crore of profit after tax for q2fy26https://www.pharmaradar360.com/article/natco-receives-tentative-approval-for-erdafitinib-tablets-generic-of-balversa-fr-60f9b7ecb306a3dcPharma Surgeen2026-06-20T00:00:00.000Znatco receives tentative approval for erdafitinib tablets generic of balversa from the united states food and drug administration u s fdahttps://www.pharmaradar360.com/article/natco-receives-approval-from-central-drug-standard-control-organisation-cdsco-fo-f91deaadbb762ed5Pharma Surgeen2026-06-20T00:00:00.000Znatco receives approval from central drug standard control organisation cdsco for semaglutide in indiahttps://www.pharmaradar360.com/article/natco-pharma-limited-api-unit-in-chennai-receives-establishment-inspection-repor-faa4978598695a1dPharma Surgeen2026-06-20T00:00:00.000Znatco pharma limited api unit in chennai receives establishment inspection report eir from u s fdahttps://www.pharmaradar360.com/article/natco-pharma-launches-semaglutide-generic-injection-multi-dose-vials-in-india-at-6c2c596bfb0e92c3Pharma Surgeen2026-06-20T00:00:00.000Znatco pharma launches semaglutide generic injection multi dose vials in india at the most affordable price starting from mrp inr 1290https://www.pharmaradar360.com/article/natco-announces-launch-of-pomalidomide-capsules-generic-of-pomalyst-in-the-u-s-m-f1ff97cd5b267c91Pharma Surgeen2026-06-20T00:00:00.000Znatco announces launch of pomalidomide capsules generic of pomalyst in the u s markethttps://www.pharmaradar360.com/article/natco-announces-launch-of-its-everolimus-tablets-1-mg-generic-of-zortress-79695697483ad94ePharma Surgeen2026-06-20T00:00:00.000Znatco announces launch of its everolimus tablets 1 mg generic of zortresshttps://www.pharmaradar360.com/article/natco-and-lupin-receive-approval-from-u-s-fda-for-eribulin-mesylate-injection-fb07b5dab809ab6ePharma Surgeen2026-06-20T00:00:00.000Znatco and lupin receive approval from u s fda for eribulin mesylate injectionhttps://www.pharmaradar360.com/article/intimation-under-regulation-30-of-sebi-listing-obligations-and-disclosure-requir-98c7815b824910c9Pharma Surgeen2026-06-20T00:00:00.000Zintimation under regulation 30 of sebi listing obligations and disclosure requirements regulations 2015 2https://www.pharmaradar360.com/article/disclosure-under-regulation-30-of-the-sebi-listing-obligations-and-disclosure-re-8f36254463893fa5Pharma Surgeen2026-06-20T00:00:00.000Zdisclosure under regulation 30 of the sebi listing obligations and disclosure requirements regulations 2015https://www.pharmaradar360.com/article/adcock-ingram-completes-delisting-from-jse-natco-pharma-acquires-35-75-stake-b8d56474f7b85e29Pharma Surgeen2026-06-20T00:00:00.000Zadcock ingram completes delisting from jse natco pharma acquires 35 75 stakehttps://www.pharmaradar360.com/article/home-page-1a664f22173fe49bPharma Surgeen2026-06-20T00:00:00.000ZHome pagehttps://www.pharmaradar360.com/article/la-ricerca-di-policlinico-di-milano-universita-degli-studi-di-milano-protagonist-c238d3c23fd4bef3Pharma Surgeen2026-06-19T22:24:00.000ZLa ricerca di Policlinico di Milano-Università degli Studi di Milano protagonista all’European Hematology Associationhttps://www.pharmaradar360.com/article/alfredo-gaete-asume-la-direccion-del-campus-villarrica-con-foco-en-el-territorio-63ecc5aacf196877Pharma Surgeen2026-06-19T19:11:55.000ZAlfredo Gaete asume la dirección del campus Villarrica con foco en el territoriohttps://www.pharmaradar360.com/article/asco-2026-next-generation-immunotherapies-16e02b4d6d688f57Pharma Surgeen2026-06-19T18:44:28.000ZASCO 2026: Next-Generation Immunotherapieshttps://www.pharmaradar360.com/article/art-show-features-work-from-45-student-artists-34b172110e0431caPharma Surgeen2026-06-19T17:52:20.000ZArt show features work from 45 student artistshttps://www.pharmaradar360.com/article/on-behalf-of-respighi-bidco-s-p-a-press-release-pursuant-to-article-38-paragraph-8637762fcce8990fPharma Surgeen2026-06-19T17:49:09.000ZOn behalf of Respighi BidCo S.p.A – Press Release pursuant to Article 38, paragraph 1, of the Issuers’ Regulation – Suspension of the review periodhttps://www.pharmaradar360.com/article/college-world-series-means-special-father-s-day-for-carolina-coach-family-1a4fe4c6c037eedcPharma Surgeen2026-06-19T17:34:58.000ZCollege World Series means special Father’s Day for Carolina coach, familyhttps://www.pharmaradar360.com/article/this-fan-worked-for-crawdads-panthers-and-bulls-d3bf19df14428f8fPharma Surgeen2026-06-19T17:34:41.000ZThis fan worked for Crawdads, Panthers and Bullshttps://www.pharmaradar360.com/article/resultados-del-ranking-qs-destacan-fortalecimiento-de-la-experiencia-formativa-e-57330615198b2eeePharma Surgeen2026-06-19T17:26:16.000ZResultados del ranking QS destacan fortalecimiento de la experiencia formativa en la UChttps://www.pharmaradar360.com/article/mmi-partners-with-joslyn-castle-to-staff-carriage-house-cafe-6fdc76ff349f30caPharma Surgeen2026-06-19T16:58:57.000ZMMI partners with Joslyn Castle to staff Carriage House Cafehttps://www.pharmaradar360.com/article/anmat-fortalece-su-capacidad-de-referencia-regional-en-el-control-de-vacunas-ant-dacdc46d441bbe86Pharma Surgeen2026-06-19T16:48:38.000ZANMAT fortalece su capacidad de referencia regional en el control de vacunas antigripaleshttps://www.pharmaradar360.com/article/garden-walk-draws-thousands-for-good-cause-6be9e41e5e38719bPharma Surgeen2026-06-19T16:46:19.000ZGarden Walk draws thousands for good causehttps://www.pharmaradar360.com/article/medhealth-outlook-altasciences-drug-development-that-is-faster-by-design-28f42083774a4d7bPharma Surgeen2026-06-19T16:38:12.000ZMedhealth Outlook: Altasciences - Drug Development That is Faster by Designhttps://www.pharmaradar360.com/article/mmi-voices-occupational-therapy-summer-camps-offer-fun-friendship-and-skill-buil-28edb7421eea5869Pharma Surgeen2026-06-19T16:19:37.000ZMMI Voices: Occupational therapy summer camps offer fun, friendship and skill buildinghttps://www.pharmaradar360.com/article/pharmaceutical-executive-daily-fda-advisory-committee-votes-unanimously-in-favor-e4933408b042bd66Pharma Surgeen2026-06-19T16:04:37.000ZPharmaceutical Executive Daily: FDA Advisory Committee Votes Unanimously in Favor of The Benefit-Risk Profile of Moderna's mRNA-1010https://www.pharmaradar360.com/article/la-unlp-consolida-su-lugar-a-nivel-nacional-y-se-mantiene-entre-las-mejores-del-7ec125b6acedd896Pharma Surgeen2026-06-19T15:50:51.000ZLa UNLP consolida su lugar a nivel nacional y se mantiene entre las mejores del mundo en el ranking QShttps://www.pharmaradar360.com/article/homenaje-a-la-bandera-en-los-jardines-del-rectorado-8326c312b5ac6204Pharma Surgeen2026-06-19T15:50:11.000ZHomenaje a la Bandera en los jardines del Rectoradohttps://www.pharmaradar360.com/article/signing-in-to-mychart-with-your-nhs-login-55dd9efea79e578ePharma Surgeen2026-06-19T15:49:45.000ZSigning in to MyChart with your NHS loginhttps://www.pharmaradar360.com/article/ai-readiness-in-pharma-getting-the-foundation-right-709c81fe69ec3e32Pharma Surgeen2026-06-19T15:20:37.000ZAI Readiness in Pharma – Getting the Foundation Righthttps://www.pharmaradar360.com/article/prof-dr-matthias-guckenberger-ubergibt-estro-prasidentschaft-e4ade8f3e426a8b8Pharma Surgeen2026-06-19T15:01:40.000ZProf. Dr. Matthias Guckenberger übergibt ESTRO-Präsidentschafthttps://www.pharmaradar360.com/article/wildlife-in-chornobyl-is-changing-its-behaviour-during-russian-invasion-d1c53a24c39be9faPharma Surgeen2026-06-19T14:37:34.000ZWildlife in Chornobyl is changing its behaviour during Russian invasionhttps://www.pharmaradar360.com/article/congressman-proposes-draft-legislation-to-accelerate-us-clinical-trials-d363bf1ab8cd0470Pharma Surgeen2026-06-19T14:32:26.000ZCongressman proposes draft legislation to accelerate US clinical trialshttps://www.pharmaradar360.com/article/qs-world-university-rankings-2027-the-university-of-freiburg-ranks-among-the-top-95fe9d76619c26fePharma Surgeen2026-06-19T14:30:04.000ZQS World University Rankings 2027: The University of Freiburg ranks among the top 10 nationally across several indicatorshttps://www.pharmaradar360.com/article/pharma-funding-roudup-kardigan-announces-400-million-initial-ipo-campfield-launc-f87fd6eaacec60bdPharma Surgeen2026-06-19T14:09:52.000ZPharma Funding Roudup: Kardigan Announces $400 Million Initial IPO, cAMPfield Launches with $180 million Series Ahttps://www.pharmaradar360.com/article/think-you-re-eating-healthy-you-may-be-missing-this-heart-protecting-nutrient-0f351bb3f1252353Pharma Surgeen2026-06-19T13:56:05.000ZThink you're eating healthy? You may be missing this heart-protecting nutrienthttps://www.pharmaradar360.com/article/eye-opening-study-highlights-connection-between-hpv-and-uveitis-641f5b6f51f2f1a6Pharma Surgeen2026-06-19T13:54:42.000ZEye-opening study highlights connection between HPV and uveitishttps://www.pharmaradar360.com/article/fda-advisory-committee-votes-unanimously-in-favor-of-the-benefit-risk-profile-of-7172dd078f9e2e5aPharma Surgeen2026-06-19T13:43:05.000ZFDA Advisory Committee Votes Unanimously in Favor of the Benefit-Risk Profile of mRNA-1010https://www.pharmaradar360.com/article/vinculaciones-municipios-unlp-2026-48704d87014cfb42Pharma Surgeen2026-06-19T13:30:47.000ZVINCULACIONES MUNICIPIOS – UNLP 2026https://www.pharmaradar360.com/article/acreditados-acreditacion-de-proyectos-i-d-y-ppid-2026-296f12611a5f13f7Pharma Surgeen2026-06-19T13:13:49.000ZAcreditados | Acreditación de Proyectos I+D y PPID 2026https://www.pharmaradar360.com/article/alert-carolina-sirens-test-to-be-held-june-23-82a958f08000d92bPharma Surgeen2026-06-19T13:09:57.000ZAlert Carolina sirens test to be held June 23https://www.pharmaradar360.com/article/universitat-heidelberg-humboldt-professur-fur-internationalen-spitzenforscher-180c8e1920a6638bPharma Surgeen2026-06-19T13:07:08.000ZUniversität Heidelberg: Humboldt-Professur für internationalen Spitzenforscherhttps://www.pharmaradar360.com/article/the-naming-patterns-behind-12-000-biotech-companies-3bfa31c6da139cd7Pharma Surgeen2026-06-19T13:00:00.000ZThe Naming Patterns Behind 12,000 Biotech Companieshttps://www.pharmaradar360.com/article/compras-y-contrataciones-75de4b64a2b8dda2Pharma Surgeen2026-06-19T12:45:04.000ZCompras y Contratacioneshttps://www.pharmaradar360.com/article/essex-partnership-digital-tool-improves-leg-wound-and-ulcer-care-1d2461036ff6049ePharma Surgeen2026-06-19T12:30:20.000ZEssex Partnership digital tool improves leg wound and ulcer carehttps://www.pharmaradar360.com/article/volontariato-22-06-cieli-azzurri-concerto-jazz-per-i-bambini-del-policlinico-di-b0a47990799375ecPharma Surgeen2026-06-19T12:00:00.000Z#VOLONTARIATO [22.06] Cieli Azzurri, concerto jazz per i bambini del Policlinico di Milanohttps://www.pharmaradar360.com/article/dna-in-neurons-is-damaged-and-repaired-during-brain-cortex-formation-32f05abae71e89bdPharma Surgeen2026-06-19T12:00:00.000ZDNA in neurons is damaged and repaired during brain cortex formationhttps://www.pharmaradar360.com/article/eu-commission-s-draft-legislation-on-pesticides-european-re-searchers-highlight-5118e4fd09fbf130Pharma Surgeen2026-06-19T11:55:06.000ZEU Commission’s draft legislation on pesticides: European re-searchers highlight the riskshttps://www.pharmaradar360.com/article/scientists-reprogram-brain-immune-cells-to-fight-alzheimer-s-0050dbc6bf29b77ePharma Surgeen2026-06-19T11:47:55.000ZScientists reprogram brain immune cells to fight Alzheimer’shttps://www.pharmaradar360.com/article/universitat-heidelberg-humboldt-professorship-for-leading-international-research-76b7402e082f54e0Pharma Surgeen2026-06-19T11:46:44.000ZUniversität Heidelberg: Humboldt Professorship for Leading International Researcherhttps://www.pharmaradar360.com/article/eu-mdr-change-control-for-samd-greenlight-guru-1472c7cf4fb5e3bePharma Surgeen2026-06-19T11:43:43.000ZEU MDR change control for SaMD | Greenlight Guruhttps://www.pharmaradar360.com/article/new-laser-system-delivers-first-experiment-3fee86eacc65bc9cPharma Surgeen2026-06-19T11:34:24.000ZNew laser system delivers first experimenthttps://www.pharmaradar360.com/article/tauber-recorrio-las-obras-finalizadas-del-primer-modulo-de-viviendas-del-barrio-8002ca76774d344ePharma Surgeen2026-06-19T11:02:44.000ZTauber recorrió las obras finalizadas del primer módulo de viviendas del barrio estudiantilhttps://www.pharmaradar360.com/article/facundo-manes-conversara-sobre-inteligencia-artificial-y-salud-cerebral-efec5228f36932eaPharma Surgeen2026-06-19T11:00:17.000ZFacundo Manes conversará sobre inteligencia artificial y salud cerebralhttps://www.pharmaradar360.com/article/researchers-caught-in-the-crossfire-as-companies-and-government-grapple-over-ai-f70612d3c2b53842Pharma Surgeen2026-06-19T11:00:00.000ZResearchers caught in the crossfire as companies and government grapple over AI safetyhttps://www.pharmaradar360.com/article/biopharma-industry-confidence-at-highest-in-years-despite-geopolitical-headwinds-a20547ecb396f6a6Pharma Surgeen2026-06-19T10:16:19.000ZBiopharma industry confidence at highest in years despite geopolitical headwindshttps://www.pharmaradar360.com/article/biopharma-industry-confidence-at-highest-in-years-despite-geopolitical-headwinds-8ec301d2ae549518Pharma Surgeen2026-06-19T10:14:21.000ZBiopharma industry confidence at highest in years despite geopolitical headwindshttps://www.pharmaradar360.com/article/redefining-obesity-success-in-the-glp-1-era-q-a-with-brian-hilberdink-665fa0da570717e7Pharma Surgeen2026-06-19T10:00:00.000ZRedefining Obesity Success in the GLP-1 Era: Q&A with Brian Hilberdinkhttps://www.pharmaradar360.com/article/additive-manufacturing-s-application-in-pharma-and-biotech-a099dc63a5b655d0Pharma Surgeen2026-06-19T10:00:00.000ZAdditive Manufacturing's Application in Pharma and Biotechhttps://www.pharmaradar360.com/article/cough-cold-40c860f6164242e6Pharma Surgeen2026-06-19T09:37:28.000ZCough & coldhttps://www.pharmaradar360.com/article/pain-management-d9e4e0976d5390c2Pharma Surgeen2026-06-19T09:37:28.000ZPain managementhttps://www.pharmaradar360.com/article/neurology-f7b888abe5e9954dPharma Surgeen2026-06-19T09:37:28.000ZNeurologyhttps://www.pharmaradar360.com/article/cardiometabolic-55f316b8ffedde64Pharma Surgeen2026-06-19T09:37:28.000ZCardiometabolichttps://www.pharmaradar360.com/article/intim-health-38481782985ae775Pharma Surgeen2026-06-19T09:37:28.000ZIntim healthhttps://www.pharmaradar360.com/article/gastroenterology-db667852b267ab08Pharma Surgeen2026-06-19T09:37:28.000ZGastroenterologyhttps://www.pharmaradar360.com/article/skin-care-7e1b6c48d5111143Pharma Surgeen2026-06-19T09:37:28.000ZSkin carehttps://www.pharmaradar360.com/article/antibiotics-and-antiseptics-9b63c4b840c2498cPharma Surgeen2026-06-19T09:37:28.000ZAntibiotics and antisepticshttps://www.pharmaradar360.com/article/drugs-for-allergy-657ba55a3349b026Pharma Surgeen2026-06-19T09:37:28.000ZDrugs for Allergyhttps://www.pharmaradar360.com/article/a293183fa4cea2d6Pharma Surgeen2026-06-19T09:37:28.000ZПрепарати від застуди та температуриhttps://www.pharmaradar360.com/article/c9096316a383ba67Pharma Surgeen2026-06-19T09:37:28.000ZПрепарати від болю та запаленняhttps://www.pharmaradar360.com/article/be396434edbd842aPharma Surgeen2026-06-19T09:37:28.000ZНеврологічні препаратиhttps://www.pharmaradar360.com/article/90adad598dc9666fPharma Surgeen2026-06-19T09:37:28.000ZКардіометаболічні препаратиhttps://www.pharmaradar360.com/article/31cd924d74b532a8Pharma Surgeen2026-06-19T09:37:28.000ZПрепарати для інтимного здоров'яhttps://www.pharmaradar360.com/article/0b511211ba033cdaPharma Surgeen2026-06-19T09:37:28.000ZПрепарати для застосування у хірургіїhttps://www.pharmaradar360.com/article/430e07c2cd992676Pharma Surgeen2026-06-19T09:37:28.000ZГастроентерологічні препаратиhttps://www.pharmaradar360.com/article/c7ce3abe48554e7cPharma Surgeen2026-06-19T09:37:28.000ZДерматологічні препаратиhttps://www.pharmaradar360.com/article/6864487b8f92044ePharma Surgeen2026-06-19T09:37:28.000ZАнтибактеріальні препарати та антисептикиhttps://www.pharmaradar360.com/article/7770ad809e2f30cePharma Surgeen2026-06-19T09:37:28.000ZПрепарати при алергіїhttps://www.pharmaradar360.com/article/f49d54c872db6b8dPharma Surgeen2026-06-19T09:37:28.000ZПрепаратиhttps://www.pharmaradar360.com/article/shionogi-and-f2g-report-positive-top-line-data-from-phase-iii-oasis-study-c63c475b3b515f27Pharma Surgeen2026-06-19T09:36:54.000ZShionogi and F2G report positive top line data from Phase III OASIS studyhttps://www.pharmaradar360.com/article/volunteers-transform-hospital-garden-into-welcoming-outdoor-space-2f2618e4892b695ePharma Surgeen2026-06-19T09:31:23.000ZVolunteers transform hospital garden into welcoming outdoor spacehttps://www.pharmaradar360.com/article/world-cup-stadiums-almost-full-despite-high-ticket-prices-says-sports-economist-4783817d4c987cc3Pharma Surgeen2026-06-19T09:24:37.000ZWorld Cup stadiums almost full despite high ticket prices, says sports economist Thomas Peetershttps://www.pharmaradar360.com/article/supporter-runs-arctic-marathon-for-guy-s-cancer-charity-1f9c52ee2ff69173Pharma Surgeen2026-06-19T09:23:22.000ZSupporter runs Arctic marathon for Guy's Cancer Charityhttps://www.pharmaradar360.com/article/voro-and-alloy-partner-on-tumour-selective-tce-therapeutics-4313a5f22f6ce4e8Pharma Surgeen2026-06-19T09:22:14.000ZVoro and Alloy partner on tumour-selective TCE therapeuticshttps://www.pharmaradar360.com/article/maia-activates-new-site-for-thio-101-phase-ii-trial-ebbf38ce21755cccPharma Surgeen2026-06-19T09:03:10.000ZMAIA activates new site for THIO-101 Phase II trialhttps://www.pharmaradar360.com/article/biogen-to-acquire-raythera-for-up-to-1bn-89e58495b78920d6Pharma Surgeen2026-06-19T08:48:18.000ZBiogen to acquire RayThera for up to $1bnhttps://www.pharmaradar360.com/article/fda-warning-slams-zoll-medical-with-multiple-quality-control-and-reporting-viola-00a53e75c2aa7d14Pharma Surgeen2026-06-19T08:26:00.000ZFDA warning slams Zoll Medical with multiple quality control and reporting violationshttps://www.pharmaradar360.com/article/universitatsklinikum-essen-besteht-tuv-uberwachungsaudit-nach-iso-9001-erneut-er-5668cf604f7f9301Pharma Surgeen2026-06-19T08:19:47.000ZUniversitätsklinikum Essen besteht TÜV-Überwachungsaudit nach ISO 9001 erneut erfolgreichhttps://www.pharmaradar360.com/article/asco26-rlts-bring-the-buzz-but-commercial-and-tolerability-qualms-remain-4d21d89dfa4d9b7dPharma Surgeen2026-06-19T08:13:51.000ZASCO26: RLTs bring the buzz, but commercial and tolerability qualms remainhttps://www.pharmaradar360.com/article/welcome-prof-dr-fabian-michl-professor-of-public-law-ed8030584c161d19Pharma Surgeen2026-06-19T08:10:57.000ZWelcome: Prof. Dr Fabian Michl, Professor of Public Lawhttps://www.pharmaradar360.com/article/information-about-the-criminal-offence-committed-by-a-former-employee-of-the-uni-2784e3991f65878cPharma Surgeen2026-06-19T08:08:00.000ZInformation about the criminal offence committed by a former employee of the University of Freiburghttps://www.pharmaradar360.com/article/ai-lab-midjourney-investing-over-74m-to-launch-whole-body-ultrasound-screening-b-d870bdd06a2d0565Pharma Surgeen2026-06-19T08:07:09.000ZAI lab Midjourney investing over $74M to launch whole-body ultrasound screening businesshttps://www.pharmaradar360.com/article/vague-de-chaleur-activation-du-numero-vert-canicule-info-service-au-0800-06-66-6-87145c4cb2b9aa20Pharma Surgeen2026-06-19T08:03:17.000ZVague de chaleur Activation du numéro vert « Canicule info service » au 0800 06 66 66https://www.pharmaradar360.com/article/light-in-a-bottle-liquid-can-harvest-and-store-energy-from-multiple-sources-26e59b04ec5b851fPharma Surgeen2026-06-19T08:00:00.000Z‘Light in a bottle’ liquid can harvest and store energy from multiple sourceshttps://www.pharmaradar360.com/article/bio-international-convention-2026-practical-advice-from-former-evotec-ceo-werner-3edaa7e62a75379fPharma Surgeen2026-06-19T08:00:00.000ZBIO International Convention 2026: practical advice from former Evotec CEO Werner Lanthalerhttps://www.pharmaradar360.com/article/ukri-announces-new-non-executive-member-77253f55f8d7dba7Pharma Surgeen2026-06-19T07:47:27.000ZUKRI announces new non-executive memberhttps://www.pharmaradar360.com/article/interventional-work-increasingly-concentrated-among-smaller-subset-of-radiologis-5c20fc9a4761bf01Pharma Surgeen2026-06-19T07:33:42.000ZInterventional work increasingly concentrated among smaller subset of radiologistshttps://www.pharmaradar360.com/article/senate-passes-radiologist-supported-bill-to-bolster-lung-cancer-research-bc1eccc83b0ddcd7Pharma Surgeen2026-06-19T07:30:13.000ZSenate passes radiologist-supported bill to bolster lung cancer researchhttps://www.pharmaradar360.com/article/25-000-genomes-for-brain-health-18c603864a0f0c0bPharma Surgeen2026-06-19T07:30:00.000Z25,000 Genomes for Brain Healthhttps://www.pharmaradar360.com/article/universitatsklinika-legen-angebot-vor-tarifabschluss-muss-dauerhaft-finanzierbar-c9ffa6c2e98bb7ecPharma Surgeen2026-06-19T07:27:58.000ZUniversitätsklinika legen Angebot vor: „Tarifabschluss muss dauerhaft finanzierbar bleiben“https://www.pharmaradar360.com/article/balancing-benefit-and-risk-nisha-vora-on-the-science-of-pharmacovigilance-2e418fe8f156c90ePharma Surgeen2026-06-19T07:00:00.000ZBalancing benefit and risk: Nisha Vora on the science of pharmacovigilancehttps://www.pharmaradar360.com/article/fat-associated-liver-disease-plays-a-key-role-in-the-development-of-liver-cancer-20bd4f37723eba96Pharma Surgeen2026-06-19T07:00:00.000ZFat-associated liver disease plays a key role in the development of liver cancerhttps://www.pharmaradar360.com/article/an-unknown-reality-when-menstruation-worsens-food-allergy-68325f1957dbc372Pharma Surgeen2026-06-19T07:00:00.000ZAn unknown reality: when menstruation worsens food allergyhttps://www.pharmaradar360.com/article/west-midlands-nhs-imaging-programme-enters-procurement-f51281be71511422Pharma Surgeen2026-06-19T06:30:28.000ZWest Midlands NHS imaging programme enters procurementhttps://www.pharmaradar360.com/article/ssc-meets-to-discuss-kemri-in-the-new-era-13ddfaefc097c42dPharma Surgeen2026-06-19T06:30:18.000ZSSC Meets to Discuss “KEMRI in the New Era”https://www.pharmaradar360.com/article/iga-0ac17d5f6974c58fPharma Surgeen2026-06-19T06:30:02.000Zスパルセンタン、IgA腎症に対し国内で製造販売承認申請https://www.pharmaradar360.com/article/chugai-files-new-drug-application-in-japan-for-sparsentan-for-the-treatment-of-i-16c6fbd77c85b28cPharma Surgeen2026-06-19T06:30:02.000ZChugai Files New Drug Application in Japan for Sparsentan for the Treatment of IgA Nephropathyhttps://www.pharmaradar360.com/article/2-24a322bc5ae3c0a0Pharma Surgeen2026-06-19T06:30:01.000Zアバスチン、神経線維腫症2型に対する世界初の治療薬として、適応追加の承認を取得https://www.pharmaradar360.com/article/avastin-receives-approval-for-additional-indication-as-the-world-rsquo-s-first-t-a590b741b118683cPharma Surgeen2026-06-19T06:30:01.000ZAvastin Receives Approval for Additional Indication as the World’s First Treatment for Neurofibromatosis Type 2https://www.pharmaradar360.com/article/cd20-reg-4ef5716640e6ea7bPharma Surgeen2026-06-19T06:30:00.000Z抗CD20モノクローナル抗体「リツキサン®」成人期発症の頻回再発型あるいはステロイド依存性のネフローゼ症候群に対する承認取得についてhttps://www.pharmaradar360.com/article/anti-cd20-monoclonal-antibody-rituxan-reg-approved-for-adult-onset-frequently-re-808773305281a197Pharma Surgeen2026-06-19T06:30:00.000ZAnti-CD20 Monoclonal Antibody Rituxan® Approved for Adult-onset Frequently Relapsing or Steroid-dependent Nephrotic Syndromehttps://www.pharmaradar360.com/article/the-ars-legendi-faculty-award-for-excellence-in-teaching-medicine-2026-for-goes-b8d51b52b3327688Pharma Surgeen2026-06-19T06:17:00.000ZThe Ars Legendi faculty award for excellence in teaching medicine 2026 for goes to Dr. Götz Fabryhttps://www.pharmaradar360.com/article/epigenetische-therapie-neue-hoffnung-fur-gefasse-bei-diabetes-und-adipositas-64aca0356ff97f5fPharma Surgeen2026-06-19T06:10:49.000ZEpigenetische Therapie: Neue Hoffnung für Gefässe bei Diabetes und Adipositashttps://www.pharmaradar360.com/article/ac7724329b6e92f2Pharma Surgeen2026-06-19T06:00:36.000ZΔήλωση Αποθεμάτων Φαρμάκων Ανθρώπινης Χρήσηςhttps://www.pharmaradar360.com/article/this-giant-tropical-fruit-could-help-reverse-gum-disease-damage-0947cee0fa8bb636Pharma Surgeen2026-06-19T05:59:41.000ZThis giant tropical fruit could help reverse gum disease damagehttps://www.pharmaradar360.com/article/formazione-19-06-l-anziano-tra-fisiologia-e-patologia-immunosenescenza-57fec9db05248bc6Pharma Surgeen2026-06-19T05:36:00.000Z#FORMAZIONE. [19.06] L'anziano tra fisiologia e patologia. Immunosenescenzahttps://www.pharmaradar360.com/article/wegovy-subcutaneous-injection-co-promoted-with-novo-nordisk-pharma-approved-in-j-06f471360697f730Pharma Surgeen2026-06-19T05:00:00.000ZWegovy Subcutaneous Injection, Co-Promoted with Novo Nordisk Pharma, Approved in Japan for Metabolic Dysfunction-Associated Steatohepatitis (MASH)https://www.pharmaradar360.com/article/new-european-initiative-to-accelerate-drug-discovery-for-cardiometabolic-disease-e55dbf067e804d7ePharma Surgeen2026-06-19T05:00:00.000ZNew European initiative to accelerate drug discovery for cardiometabolic diseaseshttps://www.pharmaradar360.com/article/2025-90805-1223-2009-c69cdb06e2a833bbPharma Surgeen2026-06-19T03:43:08.000ZΑΝΑΚΟΙΝΩΣΗ ΣΧΕΤΙΚΑ ΜΕ ΔΙΟΡΘΩΤΙΚΟ 2025/90805 ΣΤΟΝ ΚΑΝΟΝΙΣΜΟ 1223/2009https://www.pharmaradar360.com/article/ibento-ibento-the-report-for-the-pmda-asia-office-gcp-workshop-2026-has-been-pos-97fd450d5defa28dPharma Surgeen2026-06-19T03:00:00.000Z[IBENTO][IBENTO]The report for the PMDA Asia office GCP workshop 2026 has been posted.https://www.pharmaradar360.com/article/ibento-ibento-the-report-for-the-pmda-asia-office-gmp-workshop-training-2026-has-cf04afbdc32bba1bPharma Surgeen2026-06-19T03:00:00.000Z[IBENTO][IBENTO]The report for the PMDA Asia office GMP Workshop Training 2026 has been posted.https://www.pharmaradar360.com/article/scientists-may-have-found-what-really-triggers-alzheimer-s-disease-4596ebd377209a3aPharma Surgeen2026-06-19T02:49:38.000ZScientists May Have Found What Really Triggers Alzheimer’s Diseasehttps://www.pharmaradar360.com/article/8cb401fca675637cPharma Surgeen2026-06-19T02:20:18.000Z脂肪由来のホルモン「アディポネクチン」の カロリー制限時の働きを明らかに―アディポネクチンの機能は食事条件と性別に依存する―https://www.pharmaradar360.com/article/2026-4-7-16-72c2ccea7d2f2de3Pharma Surgeen2026-06-19T01:17:51.000Z2026年度 第4回東北大学病院がんセミナー開催のお知らせ（7/16開催）https://www.pharmaradar360.com/article/estudian-el-impacto-del-calentamiento-global-en-las-comunidades-microbianas-del-ac960ee56abb42caPharma Surgeen2026-06-19T00:22:05.000ZEstudian el impacto del calentamiento global en las comunidades microbianas del suelo antárticohttps://www.pharmaradar360.com/article/santen-obtains-manufacturing-and-marketing-approval-in-japan-for-rhopressa-ophth-3ab34ee7e24a5670Pharma Surgeen2026-06-19T00:00:00.000ZSanten Obtains Manufacturing and Marketing Approval in Japan for Rhopressa® Ophthalmic Solution 0.02%, a Treatment for Glaucoma and Ocular Hypertensionhttps://www.pharmaradar360.com/article/sequence-specific-targeting-of-vegfa-genomic-dna-to-inhibit-tumor-growth-33a45816bd745dd6Pharma Surgeen2026-06-19T00:00:00.000ZSequence-specific targeting of VEGFA genomic DNA to inhibit tumor growthhttps://www.pharmaradar360.com/article/a-fatty-acid-amide-activates-myeloid-cells-and-improves-neurovascular-outcomes-i-791a7dd0cb8b1728Pharma Surgeen2026-06-19T00:00:00.000ZA fatty acid amide activates myeloid cells and improves neurovascular outcomes in retinal degenerationhttps://www.pharmaradar360.com/article/voltage-dynamics-of-cortical-dendrites-in-vivo-8d84d95a6800c639Pharma Surgeen2026-06-19T00:00:00.000ZVoltage dynamics of cortical dendrites in vivohttps://www.pharmaradar360.com/article/tryptamine-from-wake-active-monoaminergic-neurons-regulates-sleep-homeostasis-a35a2f1a951f4beePharma Surgeen2026-06-19T00:00:00.000ZTryptamine from wake-active monoaminergic neurons regulates sleep homeostasishttps://www.pharmaradar360.com/article/author-correction-mage-a4-mage-a8-targeted-tcr-based-bispecific-t-cell-engager-i-0cd078a1e77903d8Pharma Surgeen2026-06-19T00:00:00.000ZAuthor Correction: MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trialhttps://www.pharmaradar360.com/article/optimized-r2-retroelement-complexes-for-dna-insertion-into-plant-genomes-f88b4bdbee171a09Pharma Surgeen2026-06-19T00:00:00.000ZOptimized R2 retroelement complexes for DNA insertion into plant genomeshttps://www.pharmaradar360.com/article/efficient-site-specific-gene-addition-using-r2-retrotransposons-in-tobacco-and-r-f63f4d6c18fc339ePharma Surgeen2026-06-19T00:00:00.000ZEfficient site-specific gene addition using R2 retrotransposons in tobacco and ricehttps://www.pharmaradar360.com/article/author-correction-autophagic-cell-death-restricts-chromosomal-instability-during-51050cc29d6c1d04Pharma Surgeen2026-06-19T00:00:00.000ZAuthor Correction: Autophagic cell death restricts chromosomal instability during replicative crisishttps://www.pharmaradar360.com/article/briefing-chat-testosterone-and-sperm-might-get-a-boost-from-obesity-drugs-c53ed95a519900d0Pharma Surgeen2026-06-19T00:00:00.000ZBriefing Chat: Testosterone and sperm might get a boost from obesity drugshttps://www.pharmaradar360.com/article/a-long-lived-butterfly-s-secret-to-graceful-ageing-cb46d31e876d2dddPharma Surgeen2026-06-19T00:00:00.000ZA long-lived butterfly’s secret to graceful ageinghttps://www.pharmaradar360.com/article/stem-cells-banish-severe-autoimmune-disease-for-15-years-5b5c312f306cc7abPharma Surgeen2026-06-19T00:00:00.000ZStem cells banish severe autoimmune disease for 15 yearshttps://www.pharmaradar360.com/article/eyes-to-the-sky-the-many-benefits-of-bird-watching-aa2d205d3af0a561Pharma Surgeen2026-06-19T00:00:00.000ZEyes to the Sky: The Many Benefits of Bird Watchinghttps://www.pharmaradar360.com/article/driving-simulator-helps-mom-who-suffered-stroke-get-back-on-road-f55efa1d2307bb22Pharma Surgeen2026-06-19T00:00:00.000ZDriving Simulator Helps Mom Who Suffered Stroke Get Back on Roadhttps://www.pharmaradar360.com/article/dad-back-to-racing-after-kidney-transplant-battle-with-cancer-e17711e0641c1a56Pharma Surgeen2026-06-19T00:00:00.000ZDad Back to Racing After Kidney Transplant, Battle with Cancerhttps://www.pharmaradar360.com/article/photo-quiz-parasite-eggs-detected-by-ai-are-not-always-what-they-are-cracked-up-78451eaca3780b90Pharma Surgeen2026-06-18T22:31:33.000ZPhoto Quiz: Parasite eggs detected by AI are not always what they are cracked up to behttps://www.pharmaradar360.com/article/passaparola-emergenza-caldo-2026-come-proteggersi-dalle-ondate-di-calore-a20b4e278d23ad6bPharma Surgeen2026-06-18T22:29:00.000Z#PASSAPAROLA. Emergenza Caldo 2026 - Come proteggersi dalle ondate di calorehttps://www.pharmaradar360.com/article/a-6-month-pre-and-post-implementation-analysis-of-ai-augmented-screening-of-conc-8e838cc4352b852dPharma Surgeen2026-06-18T22:28:03.000ZA 6-month pre- and post-implementation analysis of AI-augmented screening of concentrated fecal wet mountshttps://www.pharmaradar360.com/article/researchers-hope-to-improve-minnesota-lakes-with-water-quality-survey-ab7649ca5cc14eebPharma Surgeen2026-06-18T22:13:56.000ZResearchers hope to improve Minnesota lakes with water quality surveyhttps://www.pharmaradar360.com/article/this-city-had-a-flooding-problem-so-it-turned-to-an-animal-that-had-been-extinct-41e135d51f6b40eePharma Surgeen2026-06-18T22:13:19.000ZThis city had a flooding problem. So it turned to an animal that had been extinct there for 400 yearshttps://www.pharmaradar360.com/article/u-of-m-researchers-awarded-2-2m-grant-to-study-causes-of-age-related-blindness-fcc10ffc2786e3fdPharma Surgeen2026-06-18T22:12:11.000ZU of M researchers awarded $2.2M grant to study causes of age-related blindnesshttps://www.pharmaradar360.com/article/can-spinal-cord-stimulation-help-reduce-chronic-pain-after-a-spinal-cord-injury-2a167e84e5768850Pharma Surgeen2026-06-18T22:10:48.000ZCan Spinal Cord Stimulation Help Reduce Chronic Pain After a Spinal Cord Injury?https://www.pharmaradar360.com/article/robert-e-gerszten-quot-la-sangre-es-una-autopista-de-informacion-entre-los-organ-cfb13150c272aa8bPharma Surgeen2026-06-18T22:00:00.000ZRobert E. Gerszten: "La sangre es una autopista de información entre los órganos"https://www.pharmaradar360.com/article/cien-estudiantes-de-primer-ano-de-arquitectura-uc-viajan-a-sao-paulo-a-estudiar-75cd21988d5c2cdaPharma Surgeen2026-06-18T21:39:25.000ZCien estudiantes de primer año de Arquitectura UC viajan a São Paulo a estudiar obras icónicashttps://www.pharmaradar360.com/article/unlocking-the-power-of-ai-in-the-biotech-industry-09b660493de1b346Pharma Surgeen2026-06-18T21:28:07.000ZUnlocking the Power of AI in the Biotech Industryhttps://www.pharmaradar360.com/article/unlocking-the-power-of-ai-in-the-biotech-industry-5cf687b80800fd59Pharma Surgeen2026-06-18T21:28:07.000ZUnlocking the Power of AI in the Biotech Industryhttps://www.pharmaradar360.com/article/comunidad-uc-lamenta-el-fallecimiento-del-profesor-leonardo-veas-perez-b4d7d6207b8d7ac0Pharma Surgeen2026-06-18T21:08:24.000ZComunidad UC lamenta el fallecimiento del profesor Leonardo Veas Pérezhttps://www.pharmaradar360.com/article/digital-humans-in-pharma-augmenting-field-teams-with-ai-powered-engagement-c789ea688bbd68e3Pharma Surgeen2026-06-18T21:00:39.000ZDigital humans in pharma: Augmenting field teams with AI-powered engagementhttps://www.pharmaradar360.com/article/digital-humans-in-pharma-augmenting-field-teams-with-ai-powered-engagement-8f4c4805f503c851Pharma Surgeen2026-06-18T21:00:39.000ZDigital humans in pharma: Augmenting field teams with AI-powered engagementhttps://www.pharmaradar360.com/article/abbvie-declares-quarterly-dividend-f5c277a7984a1e4aPharma Surgeen2026-06-18T20:05:00.000ZAbbVie Declares Quarterly Dividendhttps://www.pharmaradar360.com/article/gadolinium-based-contrast-safe-for-vulnerable-patients-new-study-says-4c141efa30cd3f6dPharma Surgeen2026-06-18T20:02:11.000ZGadolinium-based contrast safe for vulnerable patients, new study sayshttps://www.pharmaradar360.com/article/nuestra-red-2e175a475075d0f4Pharma Surgeen2026-06-18T19:50:50.000ZNuestra Redhttps://www.pharmaradar360.com/article/start-small-dream-big-why-a-global-cro-is-the-ideal-choice-for-small-biotechs-bbfd110ec4d4790aPharma Surgeen2026-06-18T19:35:48.000ZStart small, dream big: Why a global CRO is the ideal choice for small biotechshttps://www.pharmaradar360.com/article/margherita-ciervo-bafa3f0769ce03e4Pharma Surgeen2026-06-18T19:34:40.000ZMargherita Ciervohttps://www.pharmaradar360.com/article/pharmaceutical-executive-daily-fda-approves-utebzi-and-capvaxive-a639eb7de2ccc92fPharma Surgeen2026-06-18T18:53:06.000ZPharmaceutical Executive Daily: FDA Approves Utebzi and Capvaxivehttps://www.pharmaradar360.com/article/impact-of-early-life-adversity-on-epigenome-at-molecular-level-mapped-in-macaque-8e4d6adf7fdde249Pharma Surgeen2026-06-18T18:42:11.000ZImpact of Early Life Adversity on Epigenome at Molecular Level Mapped in Macaqueshttps://www.pharmaradar360.com/article/fda-warns-medical-device-manufacturer-over-mri-safe-claims-8557859ae474dfdcPharma Surgeen2026-06-18T18:41:57.000ZFDA warns medical device manufacturer over 'MRI-safe' claimshttps://www.pharmaradar360.com/article/alcami-expands-quality-packaging-and-storage-capabilities-at-tennessee-facility-2e41df72af8d6b34Pharma Surgeen2026-06-18T18:34:36.000ZAlcami Expands Quality, Packaging, and Storage Capabilities at Tennessee Facilityhttps://www.pharmaradar360.com/article/historic-biotech-ipo-merck-protillion-s-ai-deal-testing-a-lassa-rabies-vaccine-3db9a30dbeaaba13Pharma Surgeen2026-06-18T18:11:26.000ZHistoric Biotech IPO, Merck, Protillion’s AI Deal, Testing a Lassa–Rabies Vaccinehttps://www.pharmaradar360.com/article/la-palabra-universitaria-vuelve-a-circular-0d332e735cc0df03Pharma Surgeen2026-06-18T18:01:24.000ZLa Palabra Universitaria vuelve a circularhttps://www.pharmaradar360.com/article/how-wearables-can-unlock-their-full-potential-in-clinical-research-2802975753447d84Pharma Surgeen2026-06-18T17:24:02.000ZHow wearables can unlock their full potential in clinical researchhttps://www.pharmaradar360.com/article/how-biotech-executives-are-confronting-the-funding-and-regulatory-shifts-634853a1834a2fd0Pharma Surgeen2026-06-18T17:10:04.000ZHow biotech executives are confronting the funding and regulatory shiftshttps://www.pharmaradar360.com/article/biogen-expands-immunology-pipeline-with-agreement-to-acquire-raythera-inc-60c78291446144f6Pharma Surgeen2026-06-18T17:09:10.000ZBiogen Expands Immunology Pipeline with Agreement to Acquire RayThera Inc.https://www.pharmaradar360.com/article/nhsggc-celebrates-the-people-powering-research-on-red4research-day-347dfcabe5a16f1cPharma Surgeen2026-06-18T16:57:05.000ZNHSGGC celebrates the people powering research on Red4Research Dayhttps://www.pharmaradar360.com/article/rural-independent-kansas-hospitals-launch-clinically-integrated-network-6e265ce50417db4dPharma Surgeen2026-06-18T16:53:00.000ZRural, independent Kansas hospitals launch clinically integrated networkhttps://www.pharmaradar360.com/article/national-digital-health-index-shows-communities-most-at-risk-of-being-left-behin-9017b74e698d51e6Pharma Surgeen2026-06-18T16:49:21.000ZNational Digital Health Index shows communities most at risk of being left behind in the digital health erahttps://www.pharmaradar360.com/article/local-healthcare-executive-to-lead-2026-heart-walk-and-region-wide-push-for-cpr-0446b14e981d930aPharma Surgeen2026-06-18T16:37:00.000ZLocal healthcare executive to lead 2026 Heart Walk and region-wide push for CPR readinesshttps://www.pharmaradar360.com/article/we-all-just-want-to-feel-seen-heard-and-belong-una-europa-staff-week-etsi-tapoja-bee878b994a2794fPharma Surgeen2026-06-18T16:30:55.000Z“We all just want to feel seen, heard, and belong” – Una Europa Staff Week etsi tapoja katsoa yliopistoa uusin silminhttps://www.pharmaradar360.com/article/rare-dad-rare-hero-ben-wilson-ec6ea45d9af5567dPharma Surgeen2026-06-18T16:30:16.000ZRare Dad, Rare Hero: Ben Wilsonhttps://www.pharmaradar360.com/article/rare-dad-rare-hero-d-rolf-hill-8b7ca38202ef23b5Pharma Surgeen2026-06-18T16:27:51.000ZRare Dad, Rare Hero: D. Rolf Hillhttps://www.pharmaradar360.com/article/american-heart-association-names-2026-heart-of-cleveland-guiding-values-awards-w-57c7588000dbc7baPharma Surgeen2026-06-18T16:27:00.000ZAmerican Heart Association names 2026 Heart of Cleveland Guiding Values Awards Winnershttps://www.pharmaradar360.com/article/idbs-and-alchemi-agree-to-accelerate-ai-driven-biopharma-regulatory-filings-4df6f50e861b733aPharma Surgeen2026-06-18T16:18:06.000ZIDBS and Alchemi Agree to Accelerate AI-Driven Biopharma Regulatory Filingshttps://www.pharmaradar360.com/article/nwsl-s-racing-louisville-fc-participate-in-hands-only-cpr-and-aed-training-43a8184909506fd7Pharma Surgeen2026-06-18T16:11:00.000ZNWSL’S Racing Louisville FC participate in Hands-Only CPR and AED traininghttps://www.pharmaradar360.com/article/upcite-launches-its-reporting-platform-f07b448c4079925dPharma Surgeen2026-06-18T16:06:24.000ZUPCité launches its reporting platformhttps://www.pharmaradar360.com/article/denzel-ward-del-equipo-cleveland-browns-y-la-olimpica-katie-moon-lideran-la-camp-14fe9be959396acePharma Surgeen2026-06-18T16:04:00.000ZDenzel Ward del equipo Cleveland Browns y la olímpica Katie Moon lideran la campaña de Cleveland instando a los residentes a actuar como socorristashttps://www.pharmaradar360.com/article/la-american-heart-association-delta-dental-y-goodwill-inauguran-un-nuevo-centro-d4d23938268c6585Pharma Surgeen2026-06-18T16:01:00.000ZLa American Heart Association, Delta Dental y Goodwill inauguran un nuevo centro de control de la presión arterial para ampliar el acceso a la salud en la comunidadhttps://www.pharmaradar360.com/article/la-propuesta-de-un-salon-para-fumadores-en-el-dtw-pone-en-riesgo-las-medidas-de-30d1bcf1b92f626bPharma Surgeen2026-06-18T15:49:00.000ZLa propuesta de un salón para fumadores en el DTW pone en riesgo las medidas de protección contra el humohttps://www.pharmaradar360.com/article/northwestern-medicine-collaborates-with-vizlitics-to-advance-cancer-clinical-tri-ba7d60aeab07b483Pharma Surgeen2026-06-18T15:46:49.000ZNorthwestern Medicine Collaborates with Vizlitics to Advance Cancer Clinical Trial Recruitment and Real-World Datahttps://www.pharmaradar360.com/article/el-chicago-stars-de-la-nwsl-participa-en-el-entrenamiento-de-rcp-solo-con-las-ma-bfc5e6f0c75be23fPharma Surgeen2026-06-18T15:46:00.000ZEl Chicago Stars de la NWSL participa en el entrenamiento de RCP solo con las manos y el uso del DEAhttps://www.pharmaradar360.com/article/at-fda-caretaker-mode-is-better-than-power-trip-mode-2741cd1139c3d247Pharma Surgeen2026-06-18T15:44:10.000ZAt FDA, ‘caretaker mode’ is better than power trip modehttps://www.pharmaradar360.com/article/message-from-the-chair-of-the-department-of-internal-medicine-961ed43f87c3df56Pharma Surgeen2026-06-18T15:35:38.000ZMessage from the Chair of the Department of Internal Medicinehttps://www.pharmaradar360.com/article/the-role-of-immigrants-in-the-u-s-health-care-workforce-1501c2c122625330Pharma Surgeen2026-06-18T15:28:50.000ZThe Role of Immigrants in the U.S. Health Care Workforcehttps://www.pharmaradar360.com/article/h-dele-davies-md-appointed-ninth-chancellor-of-unmc-8de91ad96baec6eaPharma Surgeen2026-06-18T15:26:32.000ZH. Dele Davies, MD, appointed ninth chancellor of UNMChttps://www.pharmaradar360.com/article/ftc-orders-aurobindo-to-divest-4-drugs-to-complete-250m-lannett-acquisition-221f555ec23f3b5ePharma Surgeen2026-06-18T15:11:00.000ZFTC orders Aurobindo to divest 4 drugs to complete $250M Lannett acquisitionhttps://www.pharmaradar360.com/article/congressional-budget-office-calls-for-more-research-on-no-surprises-act-unintend-18d5e6cb60865564Pharma Surgeen2026-06-18T15:06:00.000ZCongressional Budget Office calls for more research on No Surprises Act unintended impactshttps://www.pharmaradar360.com/article/novocure-s-optune-gio-fails-to-show-benefit-at-earlier-stage-639ede908259771aPharma Surgeen2026-06-18T15:04:28.000ZNovocure’s Optune Gio fails to show benefit at earlier stagehttps://www.pharmaradar360.com/article/first-year-phd-students-applications-for-an-international-dual-phd-programme-are-e6db84bec540a533Pharma Surgeen2026-06-18T15:00:42.000ZFirst-year PhD students: applications for an International dual PhD programme are now open.https://www.pharmaradar360.com/article/riken-s-new-platform-for-quantum-hpc-hybrid-computing-c0a52f8941452054Pharma Surgeen2026-06-18T15:00:00.000ZRIKEN’s new platform for quantum-HPC hybrid computinghttps://www.pharmaradar360.com/article/new-study-projects-thousands-of-preventable-deaths-if-federal-support-for-syring-e9b185ff079f57b0Pharma Surgeen2026-06-18T15:00:00.000ZNew Study Projects Thousands of Preventable Deaths if Federal Support for Syringe Service Programs Is Reducedhttps://www.pharmaradar360.com/article/apple-announces-changes-to-ios-in-brazil-f8220c3c7ad8f694Pharma Surgeen2026-06-18T14:59:41.000ZApple announces changes to iOS in Brazilhttps://www.pharmaradar360.com/article/exploring-the-future-of-inhalation-drug-delivery-2026-cb4353c9a3d4ed7dPharma Surgeen2026-06-18T14:58:59.000ZExploring the Future of Inhalation Drug Delivery 2026https://www.pharmaradar360.com/article/ems-faz-parceria-com-a-norte-americana-biotech-para-desenvolver-tratamentos-de-a-c245865ad61ab7d1Pharma Surgeen2026-06-18T14:54:56.000ZEMS faz parceria com a norte-americana Biotech para desenvolver tratamentos de alta complexidadehttps://www.pharmaradar360.com/article/h-dele-davies-md-appointed-ninth-chancellor-of-unmc-d5bbf62d00092b3aPharma Surgeen2026-06-18T14:53:51.000ZH. Dele Davies, MD, appointed ninth chancellor of UNMChttps://www.pharmaradar360.com/article/qual-e-a-sua-verdade-dermacyd-propoe-olhar-para-a-intimidade-70636438b1162d3bPharma Surgeen2026-06-18T14:53:47.000ZQual é a sua verdade? Dermacyd propõe olhar para a intimidadehttps://www.pharmaradar360.com/article/os-impactos-da-aquisicao-da-medley-pela-ems-b9aba752ad81c452Pharma Surgeen2026-06-18T14:53:15.000ZOs impactos da aquisição da Medley pela EMShttps://www.pharmaradar360.com/article/ems-compra-medley-da-sanofi-e-reforca-aposta-no-mercado-de-genericos-a83009e2b64a0c68Pharma Surgeen2026-06-18T14:52:50.000ZEMS compra Medley da Sanofi e reforça aposta no mercado de genéricoshttps://www.pharmaradar360.com/article/medley-e-da-ems-mas-marcas-continuam-separadas-nas-gondolas-diz-vp-81c3b28404734297Pharma Surgeen2026-06-18T14:52:22.000ZMedley é da EMS, mas marcas continuam separadas nas gôndolas, diz VPhttps://www.pharmaradar360.com/article/board-of-regents-provides-update-on-nebraska-medicine-governance-a720fb9fb63d73f3Pharma Surgeen2026-06-18T14:51:00.000ZBoard of Regents provides update on Nebraska Medicine governancehttps://www.pharmaradar360.com/article/ems-quer-ampliar-debate-sobre-obesidade-com-peso-invisivel-a998851e82c30694Pharma Surgeen2026-06-18T14:51:00.000ZEMS quer ampliar debate sobre obesidade com Peso Invisívelhttps://www.pharmaradar360.com/article/regents-approve-2026-27-operating-budget-including-tuition-increase-78579c3bd8e59a8bPharma Surgeen2026-06-18T14:49:00.000ZRegents approve 2026-27 operating budget, including tuition increasehttps://www.pharmaradar360.com/article/students-alum-team-up-for-campus-ai-workshop-88245fdd36ac81c3Pharma Surgeen2026-06-18T14:48:00.000ZStudents, alum team up for campus AI workshophttps://www.pharmaradar360.com/article/wch-pride-panel-supporting-and-affirming-queer-and-trans-people-in-healthcare-d325113a23bdaec2Pharma Surgeen2026-06-18T14:46:44.000ZWCH Pride Panel: Supporting and Affirming Queer and Trans People in Healthcarehttps://www.pharmaradar360.com/article/lauded-for-leadership-4637c708c18d05fbPharma Surgeen2026-06-18T14:45:22.000ZLauded for leadershiphttps://www.pharmaradar360.com/article/ms-spotlight-treating-women-safely-in-and-around-pregnancy-354d3b133e65f7e9Pharma Surgeen2026-06-18T14:41:34.000ZMS Spotlight: Treating Women Safely In and Around Pregnancyhttps://www.pharmaradar360.com/article/sobre-a-ems-3ea5bdafc993bce1Pharma Surgeen2026-06-18T14:40:08.000ZSobre a EMShttps://www.pharmaradar360.com/article/hhs-opens-applications-for-700m-in-mental-health-addiction-funding-with-96m-for-5aa15205370408d5Pharma Surgeen2026-06-18T14:40:00.000ZHHS opens applications for $700M in mental health, addiction funding, with $96M for new STREETS programhttps://www.pharmaradar360.com/article/moderna-s-flu-candidate-sails-through-fda-advisory-committee-in-unanimous-votes-633232e523b2bea1Pharma Surgeen2026-06-18T14:37:00.000ZModerna’s flu candidate sails through FDA advisory committee in unanimous voteshttps://www.pharmaradar360.com/article/accelerating-qsp-virtual-population-generation-through-active-learning-and-bayes-2985b097cf38f6efPharma Surgeen2026-06-18T14:23:30.000ZAccelerating QSP Virtual Population Generation Through Active Learning and Bayesian Optimizationhttps://www.pharmaradar360.com/article/fda-approves-additional-indication-for-capvaxive-in-children-aged-2-17-at-increa-c034236c93bfeb35Pharma Surgeen2026-06-18T14:18:57.000ZFDA Approves Additional Indication for Capvaxive in Children Aged 2-17 at Increased Risk for Pneumococcal Diseasehttps://www.pharmaradar360.com/article/prix-gustave-roussy-2027-l-appel-a-candidatures-est-ouvert-ce4289b6ee2e3599Pharma Surgeen2026-06-18T14:06:19.000ZPrix Gustave Roussy 2027 : l’appel à candidatures est ouverthttps://www.pharmaradar360.com/article/chemaxon-presents-too-many-tools-not-enough-chemistry-1f237c44aef48aabPharma Surgeen2026-06-18T14:00:34.000ZChemaxon presents: Too Many Tools, Not Enough Chemistryhttps://www.pharmaradar360.com/article/the-microglia-derived-protein-sema4ab-attenuates-regenerative-neurogenesis-after-242cd44d47acfa64Pharma Surgeen2026-06-18T14:00:00.000ZThe microglia-derived protein sema4ab attenuates regenerative neurogenesis after spinal cord injury in zebrafishhttps://www.pharmaradar360.com/article/learning-engages-transient-and-sustained-cellular-mechanisms-in-the-human-brain-f8fa70403b02fde1Pharma Surgeen2026-06-18T14:00:00.000ZLearning engages transient and sustained cellular mechanisms in the human brainhttps://www.pharmaradar360.com/article/argonaute-2-drives-resistance-to-immune-checkpoint-inhibitors-in-immunorefractor-eee72943d1b25f94Pharma Surgeen2026-06-18T14:00:00.000ZArgonaute 2 drives resistance to immune checkpoint inhibitors in immunorefractory non-small cell lung cancerhttps://www.pharmaradar360.com/article/adiponectin-exerts-sex-dependent-effects-on-lipid-amino-acid-and-glucose-metabol-87e03a0d743e1303Pharma Surgeen2026-06-18T14:00:00.000ZAdiponectin exerts sex-dependent effects on lipid, amino acid, and glucose metabolism during caloric restrictionhttps://www.pharmaradar360.com/article/levels-of-additive-genetic-variation-vary-substantially-between-species-9ff94f6df9b5c282Pharma Surgeen2026-06-18T14:00:00.000ZLevels of additive genetic variation vary substantially between specieshttps://www.pharmaradar360.com/article/uniqure-to-seek-approval-of-huntington-s-gene-therapy-after-fda-u-turn-776d973c1701bed0Pharma Surgeen2026-06-18T13:57:22.000ZUniQure to seek approval of Huntington’s gene therapy after FDA U-turnhttps://www.pharmaradar360.com/article/mabion-reactivates-mabioncd20-through-rare-disease-collaboration-with-oddifact-ad71a7d1ef1961ebPharma Surgeen2026-06-18T13:57:15.000ZMabion reactivates MabionCD20 through rare disease collaboration with Oddifacthttps://www.pharmaradar360.com/article/placental-abruption-could-increase-risk-of-cardiovascular-disease-in-women-656a6b718e9b78f6Pharma Surgeen2026-06-18T13:51:41.000ZPlacental abruption could increase risk of cardiovascular disease in womenhttps://www.pharmaradar360.com/article/fda-approves-utebzi-for-adults-with-complicated-urinary-tract-infections-3bd1380a653184b7Pharma Surgeen2026-06-18T13:51:21.000ZFDA Approves Utebzi for Adults with Complicated Urinary Tract Infectionshttps://www.pharmaradar360.com/article/hlth-europe-2026-incorporating-rwe-into-practice-the-perks-and-pitfalls-9b02438398a7af0aPharma Surgeen2026-06-18T13:47:37.000ZHLTH Europe 2026: incorporating RWE into practice – the perks and pitfallshttps://www.pharmaradar360.com/article/tracking-implementation-of-the-2025-reconciliation-law-medicaid-work-requirement-57cac49365d67c00Pharma Surgeen2026-06-18T13:41:26.000ZTracking Implementation of the 2025 Reconciliation Law Medicaid Work Requirements: Related Resourceshttps://www.pharmaradar360.com/article/tracking-implementation-of-the-2025-reconciliation-law-medicaid-work-requirement-c89dc3ea861eea1bPharma Surgeen2026-06-18T13:41:21.000ZTracking Implementation of the 2025 Reconciliation Law Medicaid Work Requirements: 1115-waivershttps://www.pharmaradar360.com/article/tracking-implementation-of-the-2025-reconciliation-law-medicaid-work-requirement-c3e1548543288cbdPharma Surgeen2026-06-18T13:41:16.000ZTracking Implementation of the 2025 Reconciliation Law: Medicaid Work Requirements Implementation Questionshttps://www.pharmaradar360.com/article/tracking-implementation-of-the-2025-reconciliation-law-medicaid-work-requirement-a26b55418fff3fa2Pharma Surgeen2026-06-18T13:41:12.000ZTracking Implementation of the 2025 Reconciliation Law: Medicaid Work Requirements Data and Policieshttps://www.pharmaradar360.com/article/biogen-enters-1-billion-agreement-to-acquire-raythera-inc-ea1ba758d78c6b48Pharma Surgeen2026-06-18T13:30:09.000ZBiogen Enters $1 Billion Agreement to Acquire RayThera Inc.https://www.pharmaradar360.com/article/travaux-sur-le-reseau-de-tram-du-29-juin-au-28-aout-2026-d2be5b887c7bf56dPharma Surgeen2026-06-18T13:29:58.000ZTravaux sur le réseau de tram du 29 juin au 28 août 2026https://www.pharmaradar360.com/article/new-kpmg-powered-accelerator-lands-customers-faster-425841ff6ac975b4Pharma Surgeen2026-06-18T13:25:27.000ZNew KPMG-powered accelerator lands customers fasterhttps://www.pharmaradar360.com/article/pobreza-por-que-la-baja-que-muestran-los-datos-oficiales-podria-estar-sobreestim-a70a1c7b3c9734e1Pharma Surgeen2026-06-18T13:23:55.000ZPobreza: por qué la baja que muestran los datos oficiales podría estar sobreestimadahttps://www.pharmaradar360.com/article/china-sets-framework-for-advanced-therapeutic-development-b3a70f68245111c6Pharma Surgeen2026-06-18T13:20:15.000ZChina Sets Framework for Advanced Therapeutic Developmenthttps://www.pharmaradar360.com/article/labgenius-therapeutics-and-lg-chem-enter-a-research-collaboration-option-and-lic-5ada465d9f9405a7Pharma Surgeen2026-06-18T13:17:19.000ZLabGenius Therapeutics and LG Chem Enter a Research Collaboration, Option and License Agreement to Develop an AI/ML-Designed Tumour-Targeting Antibodyhttps://www.pharmaradar360.com/article/tracking-implementation-of-the-2025-reconciliation-law-medicaid-work-requirement-9a28fa39f2430cf8Pharma Surgeen2026-06-18T13:15:53.000ZTracking Implementation of the 2025 Reconciliation Law: Medicaid Work Requirementshttps://www.pharmaradar360.com/article/from-tokenism-to-trust-what-inclusive-research-looks-like-d3a41e079ecce017Pharma Surgeen2026-06-18T13:15:23.000ZFrom tokenism to trust – what inclusive research looks likehttps://www.pharmaradar360.com/article/palabras-del-presidente-fernando-tauber-en-el-inicio-de-su-gestion-2026-2030-c68fc4e36b70c407Pharma Surgeen2026-06-18T13:10:40.000ZPalabras del Presidente Fernando Tauber en el inicio de su gestión 2026-2030https://www.pharmaradar360.com/article/memoria-y-compromiso-a-11-anos-de-ni-una-menos-78797e096ec1b60aPharma Surgeen2026-06-18T13:10:13.000ZMemoria y compromiso a 11 años de Ni Una Menoshttps://www.pharmaradar360.com/article/mas-sustentable-la-unlp-redujo-un-12-su-huella-de-carbono-13694f0327e09422Pharma Surgeen2026-06-18T13:09:46.000ZMás sustentable: la UNLP redujo un 12% su huella de carbonohttps://www.pharmaradar360.com/article/la-unlp-realizo-una-nueva-colecta-de-sangre-y-jornada-integral-de-salud-78b775a4435c8185Pharma Surgeen2026-06-18T13:09:11.000ZLa UNLP realizó una nueva colecta de sangre y jornada integral de saludhttps://www.pharmaradar360.com/article/ranking-cwur-2026-la-unlp-se-consolida-como-la-segunda-universidad-de-argentina-490adda02f39a2e6Pharma Surgeen2026-06-18T13:08:42.000ZRanking CWUR 2026: la UNLP se consolida como la segunda universidad de Argentina y la 15° de América Latinahttps://www.pharmaradar360.com/article/ftc-states-sue-transgender-health-association-over-misleading-gender-care-guidan-ac87d371bfccb8a4Pharma Surgeen2026-06-18T13:00:00.000ZFTC, states sue transgender health association over 'misleading' gender care guidancehttps://www.pharmaradar360.com/article/perseverance-persistence-key-to-car-t-success-say-ross-prize-winners-carl-june-a-026b8e049ee6e550Pharma Surgeen2026-06-18T12:54:29.000ZPerseverance, Persistence Key to CAR T Success, Say Ross Prize Winners Carl June and Michel Sadelainhttps://www.pharmaradar360.com/article/hussman-alumna-hosts-fifa-world-cup-tv-series-3184d7fb2fc9898dPharma Surgeen2026-06-18T12:40:23.000ZHussman alumna hosts FIFA World Cup TV serieshttps://www.pharmaradar360.com/article/julie-enevold-brooker-oraz-gabor-sztaniszlav-zostali-wybrani-do-zarzadu-zwiazku-5f31c00ffd33c506Pharma Surgeen2026-06-18T12:31:05.000ZJulie Enevold Brooker oraz Gábor Sztaniszláv zostali wybrani do Zarządu Związku Pracodawców Innowacyjnych Firm Farmaceutycznych INFARMAhttps://www.pharmaradar360.com/article/health-minister-apologises-for-nhse-error-on-fdp-data-access-27bb98c0badd3a3dPharma Surgeen2026-06-18T12:30:14.000ZHealth minister apologises for NHSE error on FDP data accesshttps://www.pharmaradar360.com/article/decision-orphan-registered-medicinal-products-0c37863c0511be51Pharma Surgeen2026-06-18T12:24:16.000ZDecision: Orphan registered medicinal productshttps://www.pharmaradar360.com/article/prac-8-11-2026-b6ce855fab005ce3Pharma Surgeen2026-06-18T12:23:06.000ZΚύρια σημεία συνεδρίασης της Επιτροπής Αξιολόγησης Κινδύνου Φαρμακοεπαγρύπνησης (PRAC), 8 – 11 Ιουνίου 2026https://www.pharmaradar360.com/article/ancient-dna-reveals-plague-was-already-killing-humans-5-500-years-ago-d8cbdc41a5f6b20bPharma Surgeen2026-06-18T12:16:46.000ZAncient DNA reveals plague was already killing humans 5,500 years agohttps://www.pharmaradar360.com/article/nirrin-technologies-and-s-t-japan-partner-on-next-gen-protein-quantitation-tech-7ef2a671e4afa0f5Pharma Surgeen2026-06-18T12:00:17.000ZNirrin Technologies and S.T. Japan Partner on Next-Gen Protein Quantitation Techhttps://www.pharmaradar360.com/article/charles-river-joins-lilly-tunelab-to-optimize-ai-ml-platform-through-nonclinical-39298218e80e3690Pharma Surgeen2026-06-18T12:00:00.000ZCharles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertisehttps://www.pharmaradar360.com/article/leci-research-seminar-on-april-22nd-the-impact-of-the-use-of-digital-tools-outsi-fa6b61e131f5ac71Pharma Surgeen2026-06-18T11:45:10.000ZLECI Research Seminar on April 22nd: The impact of the use of digital tools outside schoolhttps://www.pharmaradar360.com/article/boston-researchers-land-9m-grant-to-advance-molecular-neuroimaging-b2161b0e065e58b2Pharma Surgeen2026-06-18T11:42:47.000ZBoston researchers land $9M grant to advance molecular neuroimaginghttps://www.pharmaradar360.com/article/coplant-studie-begru-t-3-000-teilnehmerin-in-heidelberg-dead22425a1e4809Pharma Surgeen2026-06-18T11:36:51.000ZCOPLANT-Studie begrüßt 3.000. Teilnehmerin in Heidelberghttps://www.pharmaradar360.com/article/leci-research-seminar-on-february-6th-flourishing-purpose-and-meaning-in-educati-6cb3f5d28fd58e6aPharma Surgeen2026-06-18T11:32:16.000ZLECI Research Seminar on February 6th: Flourishing, Purpose and Meaning in Educationhttps://www.pharmaradar360.com/article/tibsovo-a74376e454b023e8Pharma Surgeen2026-06-18T11:05:00.000ZTibsovohttps://www.pharmaradar360.com/article/eye-on-ai-agentic-ai-brings-bots-to-the-bench-f0091ca3eda01b21Pharma Surgeen2026-06-18T11:01:47.000ZEye on AI: Agentic AI Brings Bots to the Benchhttps://www.pharmaradar360.com/article/guidance-advice-for-consumers-5875243b09fda550Pharma Surgeen2026-06-18T11:01:43.000ZGuidance: Advice for consumershttps://www.pharmaradar360.com/article/fraunhofer-and-institut-mines-telecom-imt-to-strengthen-their-research-partnersh-54879f0b0fe92433Pharma Surgeen2026-06-18T11:00:00.000ZFraunhofer and Institut Mines Télécom (IMT) to Strengthen Their Research Partnershiphttps://www.pharmaradar360.com/article/healthcare-organizations-still-struggle-to-operationalize-ai-at-scale-arcadia-su-fc0d1fe41c927606Pharma Surgeen2026-06-18T11:00:00.000ZHealthcare organizations still struggle to operationalize AI at scale: Arcadia surveyhttps://www.pharmaradar360.com/article/bristol-myers-squibb-to-report-results-for-second-quarter-2026-on-july-30-2026-27fa87b42ec9f367Pharma Surgeen2026-06-18T10:59:00.000ZBristol Myers Squibb to Report Results for Second Quarter 2026 on July 30, 2026https://www.pharmaradar360.com/article/pfizer-hunts-for-new-cfo-as-denton-prepares-to-hang-up-gloves-wave-goodbye-to-ph-77406b48c56af5f9Pharma Surgeen2026-06-18T10:58:00.000ZPfizer hunts for new CFO as Denton prepares to hang up gloves, wave goodbye to pharmahttps://www.pharmaradar360.com/article/global-semiconductors-hiring-slows-after-q1-surge-what-this-means-for-your-secto-03a2b8277ceef604Pharma Surgeen2026-06-18T10:57:40.000ZGlobal semiconductors hiring slows after Q1 surge: What this means for your sectorhttps://www.pharmaradar360.com/article/global-semiconductors-hiring-slows-after-q1-surge-what-this-means-for-your-secto-2440096b250a3db7Pharma Surgeen2026-06-18T10:57:40.000ZGlobal semiconductors hiring slows after Q1 surge: What this means for your sectorhttps://www.pharmaradar360.com/article/su-policy-innovation-lab-helps-equip-parliament-for-ai-1c4130f529e51dbfPharma Surgeen2026-06-18T10:52:01.000ZSU Policy Innovation Lab helps equip Parliament for AIhttps://www.pharmaradar360.com/article/u-s-fda-approves-an-additional-indication-for-capvaxive-pneumococcal-21-valent-c-5d4866f007690139Pharma Surgeen2026-06-18T10:45:00.000ZU.S. FDA Approves an Additional Indication for CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) in Children and Adolescents Aged 2 through 17 at Increased Risk for Pneumococcal Diseasehttps://www.pharmaradar360.com/article/listening-attentively-to-the-people-of-rotterdam-19d05e21080d0104Pharma Surgeen2026-06-18T10:45:00.000ZListening attentively to the people of Rotterdamhttps://www.pharmaradar360.com/article/ada26-retatrutide-delivers-unprecedented-weight-loss-in-phase-iii-triumph-1-5e83af8b8b064b62Pharma Surgeen2026-06-18T10:40:05.000ZADA26: retatrutide delivers unprecedented weight loss in Phase III TRIUMPH-1https://www.pharmaradar360.com/article/digital-health-coffee-time-briefing-7c5cfe9343da5b24Pharma Surgeen2026-06-18T10:30:22.000ZDigital Health Coffee Time Briefing ☕https://www.pharmaradar360.com/article/kemri-air-pollution-centre-of-excellence-attains-international-accreditation-c2a91da3b65e3193Pharma Surgeen2026-06-18T10:23:43.000ZKEMRI Air Pollution Centre of Excellence Attains International Accreditationhttps://www.pharmaradar360.com/article/kemri-management-staff-participate-in-east-africa-regional-conference-on-public-2a50e8d1c6eaf145Pharma Surgeen2026-06-18T10:19:45.000ZKEMRI Management Staff Participate in East Africa Regional Conference on Public Administration and Regional Integrationhttps://www.pharmaradar360.com/article/expanding-the-vaccine-landscape-with-new-technologies-q-a-with-silvia-taylor-fbc918283a77836dPharma Surgeen2026-06-18T10:00:00.000ZExpanding the Vaccine Landscape with New Technologies: Q&A with Silvia Taylorhttps://www.pharmaradar360.com/article/evolving-beyond-launch-postmortems-to-real-time-optimization-ba2420854a5c268dPharma Surgeen2026-06-18T10:00:00.000ZEvolving Beyond Launch Postmortems to Real-Time Optimization